Focus on vitiligo: A generalized skin disorder

European Journal of Inflammation

Volumn 4, Issue 1, 2006, Pages 21-30

  Moretti, Silvia ^a   Amato, L ^a   Bellandi, S ^a   Fabbri, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Autoimmunity; Cytokines; Melanocytes; Oxidative stress; Vitiligo

Indexed keywords

AUTOANTIBODY; CATECHOLAMINE; CYTOKINE; STEM CELL FACTOR;

AUTOIMMUNITY; BRAIN FUNCTION; CARCINOGENESIS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MELANOCYTE; MELANOGENESIS; METABOLIC DISORDER; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SKIN PIGMENTATION; VITILIGO;

EID: 33646778129     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0600400103     Document Type: Review

References (50)

1. Hann S.K. and J. Nordlund. 2000. In Vitiligo, ed. Blackwell Science Oxford, p. 1.
2. Koga M. and T. Tango. 1988. Clinical features and course of type A and type B vitiligo. Brit. J. Dermatol. 118:223.
3. Le Poole I.C., P.K. Das, R.M. van den Wijngaard, J.D. Bos and W. Westerhof. 1993. Review of ethiopathomechanism of vitiligo: a convergence theory. Exp. Dermatol. 2:145.
4. Nath S.K., P.P. Majumder and J.J. Nordlund. 1994. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am. J. Hum. Genet. 55: 981.
5. Alkhateeb A., P.R. Fain, A. Thody, D.C. Bennett and R.A. Spritz. 2003. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families: Pigment Cell. Res. 16: 208.
6. Stetler G., W. Old, J. Talbert, C. Uhlhorn, M. Taylor, A. Fox, C. Miller, D.G. Dills, E.C. Ridgway, D.C. Bennett, P.R. Fain and R.A. Spritz. 2002. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum. Mol. Genet. 11:661.
7. Le Poole I.C., R.M. van den Wijngaard, W. Westerhof, R.P. Dutrieux and P.K. Das. 1993. Presence or absence of melanocytes in vitiligo skin: an immunohistochemical investigation. J. Invest. Dermatol. 100:816.
8. Boissy R., Y.Y. Liu, E.E. Medrano and J.J. Nordlund. 1991. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long term cultures of melanocytes from vitiligo patients. J. Invest. Dermatol. 97:395.
9. Boissy R. 2000. Histology of vitiliginous skin. In Haan S.K., Nordlund J., eds. Vitiligo: monograph on the basic and clinical science. Oxford: Blackwell Science Ltd, p.23.
10. Huang C.L., J.J. Nordlund and R. Boissy. 2002. Vitiligo: a manifestation of apoptosis? Am. J. Clin. Dermatol. 3:301.
11. Gauthier Y., M. Cario-Andre, S. Lepreux, C. Pian and A. Taieb. 2003. Melanocyte detachment after friction in non lesional skin of patients with generalized vitiligo. Br. J. Dermatol. 148:951.
12. Baker J.R. Jr. 1992. Immunologic aspects of endocrine diseases. J. Am. Med. Assoc. 268: 2899.
13. Ongenae K., N. van Geel and J.M. Naeyaert. 2003. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell. Res. 16:90.
14. Kemp E.H., E.A. Waterman, B.E. Hawes, K. O'Neill, R.V.S. Gottumukkala, D.J. Gawkrodger, A.P. Weetman and P.F. Watson. 2002. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J. Clin. Invest. 109:923.
15. Sakai C., Y. Kawakami, L.W. Law, M. Furumura and V.J. Hearing. 1997. Melanosomal proteins as melanoma-specific immune targets. Melanoma Res. 7:83.
16. Le Poole I.C., A. Wankowicz-Kalinska, R.M.J. van den Wijngaard, B.J. Nickoloff and P.K. Das. 2004. Autoimmune aspects of depigmentation in vitiligo. J. Invest. Dermatol. Symp. Proc. 9:68.
17. Hann S.K., Y.K. Park, K.Y. Chung, H.I. Kim, S. Im and J.H. Won. 1993. Peripheral lymphocyte imbalance in Koreans with active vitiligo. Int. J. Dermatol. 32:286.
18. Van den Wijngaard R.M., A. Wantowicz-Kalinska, S. Pals, J. Weening and P.K. Das. 2001. Autoimmune melanocyte destruction in vitiligo. Lab. Invest. 81:1061.
19. Le Poole I.C., R.M.J van den Wijngaard, W. Westerhof and P.K. Das. 1996. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Pathol. 148:1219.
20. Ogg G.S., P.R. Dumbar, P. Romeo, J.L. Chen and V. Cerundolo. 1998. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188:1203.
21. Zvulunov A. and N.B. Esterly. 1995. Neurocutaneous syndromes associated with pigmentary skin lesion. J. Am. Acad. Dermatol. 32:915.
22. Arnozan L. 1992. Vitiligo avec troubles nerveus sensitifs et simpathetiques: l'origine simpathetique du vitiligo. Bull. Soc. Francaise Dermatologie Syfiligrafie 29:338.
23. Picardi A., P. Pasquini, M.S. Cattaruzza, P. Gaetano, C.F. Melchi, G. Baliva, D. Camaioni, A. Tiago, D. Abeni and M. Biondi. 2003. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother. Psychosom. 72:150.
24. Al'Abadie M., M.A. Warren, S.S. Bleehn and D.J. Gawkrodger. 1995. Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study. Int. J. Dermatol. 34:837.
25. Liu P.Y., L. Bondesson, W. Lontz and O. Johansson. 1996. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study. Arch. Dermatol. Res. 288:670.
26. Elwary S.M., K. Headly and K.U. Schallreuter. 1997. Calcium homeostasis influences epidermal sweating in patients with vitiligo. Br. J. Dermatol. 137:81.
27. Cucchi M.L., P. Frattini, G. Santagostino, S. Preda and G. Orecchia. 2003. Catecholamine increase in the urine of non-segmental vitiligo especially during its active phase. Pigment Cell. Res. 16:111.
28. Schallreuter K.U., J.M. Wood, I. Ziegler, K.R. Lemke, M.R. Pittelkow, N.J. Lindsey and M. Gulich. 1994. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim. Biophys. Acta 1226:181.
29. Cummings M.P. and J.J. Nordlund. 1995. Chemical leukoderma; fact or fancy. Am. J. Contact Dermatitis 6:122.
30. Schallreuter K.U., J. Moore, J.M. Wood, W.D. Beazley, D.C. Gaze, D.J. Tobin, H.S. Marshall, A. Panske, E. Panzig and N.A. Hibberts. 1999. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J. Invest. Dermatol. Symposium Proc. 4:91.
31. Passi S., M. Grandinetti, F. Maggio, A. Stancato and C. De Luca. 1998. Epidermal oxidative stress in vitiligo. Pigment Cell. Res. 11:81.
32. Schallreuter K.U., J.M. Wood, M.R. Pittelkow, M. Gutlich, K.R. Lemke, W. Rodl, N.N. Swanson, K. Hitzemann and I. Ziegler. 1994. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263:1444.
33. Maresca V., M. Roccella, F. Roccella, E. Camera, G. Del Porto, S. Passi, P. Grammatico and M. Picardo. 1997. Increased sensitivity to peroxidase agents as a possible pathogenic factor of melanocyte damage in vitiligo. J. Invest. Dermatol. 109:310.
34. Dell'Anna L., V. Maresca, S. Briganti, E. Camera, M. Falchi and M. Picardo. 2001. Mitochondrial impairment in peripheral blood mononuclear cells during the active phases of vitiligo. J. Invest. Dermatol. 117:908.
35. Giovannelli L., S. Bellandi, V. Pitozzi, P. Fabbri, P. Dolara and S. Moretti. 2004. Increased oxidative DNA damage in mononuclear leukocytes in vitiligo. Mutation Res. 556:101.
36. Dell'Anna M.L., S. Urbanelli, A. Mastrofrancesco, E. Camera, P. Iacovelli, G. Leone, P. Manini, M. D'Ischia and M. Picardo. 2003. Alteration of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigment Cell. Res. 16:553.
37. Moellmann G., S. Klein-Angere, D.A. Scollay, J.J. Nordlund and A.B. Lerner. 1982. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J. Invest. Dermatol. 79:321.
38. Imokawa G. 2004. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell. Res. 17:96.
39. Grichnih J.M., J.A. Burch, J. Burchette and C.R. Shea. 1998. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J. Invest. Dermatol. 111:233.
40. Swope V.B., Z. Abdel-Malek, L.M. Kassem and J.J. Norlund. 1991. Interleukin 1α and 6 and tumor necrosis factor α are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J. Invest. Dermatol. 96:180.
41. Moretti S., A. Spallanzani, L. Amato, G. Hautmann, I. Gallerani and P. Fabbri. 2002. Vitiligo and epidermal microenvironment: possibile involvement of keratinocyte-derived cytokines. Arch. Dermatol. 138:274.
42. Moretti S., A. Spallanzani, L. Amato, G. Hautmann, I. Gallerani, M. Fabiani and P. Fabbri. 2002. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell. Res. 15:87.
43. Kitamura R., K. Tsukamoto, K. Harada, A. Shimuzu, S. Shimada, T. Kobayashi and G. Imokawa. 2004. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and its downstream effector, MITF-M. J. Pathol. 202:463.
44. McGill G.G., M. Horstmann, H.R. Widlund, J. Du, G. Motyckova, E.K. Nishimura, Y.L. Lin, S. Ramaswamy, W. Avery, H.F. Ding, S.A. Jordan, I.J. Jackson, S.J. Korsmeyer, T.R. Golup and D.E. Fisher. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:707.
45. Jimenez-Cervantes C., M. Marinez-Esparza, C. Perez, N. Daum, F. Solano and J.C. Garcia-Borron. 2001. Inhibition of melanogenesis in response to oxidative stress: transient down-regulation of melanocyte differentiation markers and possible involvement of microphtalmia transcription factor. J. Cell Sci. 114:2335.
46. Gauthier Y., M. Cario-Andre and A. Taieb. 2003. A critical appraisal of vitiligo etiologic theories. Is melanocytic loss a melanocytorrhagy? Pigment Cell. Res. 16:322.
47. Warfvinge K., J. Agdell, L. Andersson and A. Andersson. 1998. Attachment and detachment of human epidermal melanocytes. Acta Derm. Venereol. 70:189.
48. Hara M., M. Yaar, A. Tang, M.S. Eller, W. Reenstra and B.A. Gilchrest. 1994. Role of integrins in melanocyte attachment and dendricity. J. Cell Sci. 107:2739.
49. Tang A., M.S. Eller, M. Hara, M. Yaar, S. Hirohashi and B.A. Gilchrest. 1994. E-cadherin is the major mediator of human melanocytic adhesion to keratinocytes in vitro. J. Cell Sci. 107:983.
50. Lee A.Y., N.H. Kim, W.I. Choi and Y.H. Youm. 2005. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J. Invest. Dermatol. 124:976.